Selective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory Disorders

ADVERTISEMENT RETURN TO ISSUEPREVPerspectiveNEXTSelective p38α Inhibitors Clinically Evaluated for the Treatment of Chronic Inflammatory DisordersDavid M. Goldstein*, Andreas Kuglstatter, Yan Lou, and Michael J. SothView Author Information Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304*To whom correspondence should be addressed. Phone: +1 (973) 235-4008. Fax: +1 (973) 235-6263. E-mail: email protectedCite this: J. Med. Chem. 2010, 53, 6, 2345–2353Publication Date (Web):December 1, 2009Publication History Received27 August 2009Published online1 December 2009Published inissue 25 March 2010https://pubs.acs.org/doi/10.1021/jm9012906https://doi.org/10.1021/jm9012906review-articleACS PublicationsCopyright © 2009 American Chemical SocietyRequest reuse permissionsArticle Views4834Altmetric-Citations156LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Inflammation,Inhibition,Inhibitors,Peptides and proteins,Selectivity Get e-Alerts